Wnt拮抗剂sFRP1参与慢性根尖周炎中牙周膜细胞成骨分化
本研究探讨分泌型卷曲相关蛋白1(sFRP1)在炎症条件下人牙周膜细胞(hPDLCs)成骨分化中的作用。体外用牙龈卟啉单胞菌LPS刺激hPDLCs,检测成骨标志物和Wnt/β-catenin通路,并在Wistar大鼠根尖周炎模型中验证sFRP1抑制剂对骨丢失的影响。结果表明sFRP1参与炎症下hPDLCs成骨分化,抑制sFRP1可逆转成骨标志物下降和Wnt/β-catenin通路抑制,并减少体内根尖周病变骨丢失。
要点
- 牙龈卟啉单胞菌LPS可显著降低hPDLCs成骨标志物表达并上调sFRP1。
- 抑制sFRP1可逆转LPS对成骨标志物和Wnt/β-catenin通路的抑制。
- 动物实验中sFRP1抑制剂显著减少根尖周病变骨丢失。
核心结论
- Wnt拮抗剂sFRP1参与炎症条件下hPDLCs的成骨分化。
- 通过抑制sFRP1调控Wnt/β-catenin通路可能为慢性根尖周炎治疗提供新视角。
研究设计与样本
- 体外培养hPDLCs,在成骨诱导液中以牙龈卟啉单胞菌LPS刺激,并设sFRP1抑制与否分组。
- 采用qRT-PCR、Western blot和ELISA检测成骨标志物及经典Wnt信号通路。
- 诱导Wistar大鼠根尖周炎模型,体内验证sFRP1抑制剂对骨丢失的影响。
- 统计采用Shapiro-Wilk正态性检验后,行配对t检验或单因素方差分析,P<0.05为显著性水平。
主要发现
- 成骨诱导期间,牙龈卟啉单胞菌LPS处理hPDLCs的成骨标志物mRNA和蛋白表达显著降低(P < 0.001)。
- 牙龈卟啉单胞菌LPS处理组sFRP1表达增加(P < 0.01),Wnt/β-catenin信号通路被抑制(P < 0.01)。
- 加入sFRP1抑制剂后,成骨标志物下降(P < 0.05)和Wnt/β-catenin通路抑制(P < 0.05)均显著逆转。
- 动物实验进一步证实sFRP1抑制剂显著减少体内根尖周病变骨丢失(P < 0.0001)。
临床怎么用
- 提示sFRP1可能作为慢性根尖周炎骨破坏的潜在干预靶点。
- 抑制sFRP1或调控Wnt/β-catenin通路可能有助于改善炎症下的成骨分化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To explore the mechanism of secreted frizzled-related protein I (sFRP1) involvement in the osteogenic differentiation of human periodontal ligament cells (hPDLCs) under inflammatory conditions. METHODOLOGY: hPDLCs were cultured in an osteogenic differentiation-inducing medium (odi) and subjected to the stimulation of Porphyromonas gingivalis lipopolysaccharide (P. gingivalis LPS) with or without the inhibition of sFRP1. Quantitative real-time polymerase chain reaction, Western blot and enzyme-linked immunosorbent assay were carried out to evaluate the expression of osteogenic markers as well as the classic Wnt signalling pathway. Periapical periodontitis was induced in Wistar rats to further confirm the effect of sFRP1 inhibitor on bone loss in vivo. After the Shapiro-Wilk normality test, data were analysed by Student's paired t-test or one-way Anova test with a P value less than 0.05 as the level of statistical significance. RESULTS: Significantly decreased mRNA and protein expression of osteogenic markers were detected in hPDLCs treated with P. gingivalis LPS during osteogenic induction (P < 0.001). Increased expression of sFRP1 was observed (P < 0.01), whilst Wnt/β-catenin signalling pathway was inhibited by the addition of P. gingivalis LPS (P < 0.01). After the addition of the sFRP1 inhibitor, the decrease of osteogenic markers (P < 0.05) and the inhibition of Wnt/β-catenin signalling pathway (P < 0.05) were reversed significantly. The animal experiment further confirmed that the sFRP1 inhibitor significantly reduced bone loss of periapical lesions in vivo (P < 0.0001). CONCLUSIONS: Wnt antagonist sFRP1 was involved in the osteogenic differentiation of hPDLCs under inflammation. Modulation of the Wnt/β-catenin signalling pathway through the inhibition of sFRP1 may offer a new perspective on the treatment of chronic apical periodontitis.
引用
- Yang F, Huang D, Xu L, et al. Wnt antagonist secreted frizzled-related protein I (sFRP1) may be involved in the osteogenic differentiation of periodontal ligament cells in chronic apical periodontitis. Int Endod J. 2021. PMID: 33290588. doi:10.1111/iej.13461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。